Clinical Trials

151 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06357754 2026-01-22

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

LymphoidOther hematologic neoplasmPlasma cell

50 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, B-Cell

NCT05366881 2026-01-20

CAMPERR

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

7,000 enrolled

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06125795 2026-01-12

PROVIDENCE

132 enrolled

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Patient Preference

NCT05228158 2026-01-02

A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

145 enrolled

Lymphoma, Follicular

NCT04307134 2025-12-31

Besponsa Post Marketing Surveillance Study

108 enrolled 39 charts

Burkitt Lymphoma, Hematologic Neoplasms

NCT04837222 2025-12-24

A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

1,000 enrolled

Lymphoma

NCT06985576 2025-12-18

Long-term Study to Evaluate Safety and Persistence of GF-CART01

Not yet recruiting

18 enrolled

LymphoidSarcoma

Lymphoma, Follicular, Dendritic Cell Sarcoma, Interdigitating

NCT03342144 2025-12-08

VeRVe

500 enrolled

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05923112 2025-12-05

BESPONSA Injection 1 mg Special Investigation

421 enrolled 18 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04178317 2025-12-04

A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice

14 enrolled

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05645172 2025-12-01

RETAIN

137 enrolled

Leukemia, B-Cell

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

200 enrolled

Lymphoma, Follicular, Psoriasis

NCT06362044 2025-11-25

A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan

89 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03816683 2025-11-14

SUMMIT

227 enrolled

Lymphoma, Mantle-Cell

NCT06548152 2025-10-27

AQUALIS

120 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07189806 2025-09-24

MAPLE-UK

250 enrolled

LymphoidOtherThoracic

Asthma, Bronchial Spasm, Cough, Disease, Dyspnea, Inflammation, Lymphoma, Follicular

NCT05326308 2025-09-23

ARIADNE

705 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT06358001 2025-09-22

EchoTip AcuCore Post-Market Clinical Study

EndocrineGastrointestinalLymphoidNET

183 enrolled

Autoimmune Pancreatitis, Adenocarcinoma, Carcinoma, Hepatocellular, Lymphoma, Neoplasm Metastasis, Cholangiocarcinoma, Neuroendocrine Tumors, Pancreatitis, Chronic

NCT07132567 2025-09-22

Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

15 enrolled

Mycosis Fungoides, Sezary Syndrome

NCT06274788 2025-09-05

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

40 enrolled

Malnutrition, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04872621 2025-09-02

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

104 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07145411 2025-08-28

HOPE

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

10 enrolled

Anemia, Aplastic, Anemia, Sickle Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06476665 2025-08-19

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

7 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06461351 2025-08-07

Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

1,000 enrolled

B-cell Tumors

NCT07099079 2025-08-01

Post-Market Clinical Follow-Up Study on the Rotational Stability of an Intraocular Lens After Cataract Surgery

Not yet recruiting

92 enrolled

Cataract, Intraocular Lymphoma

NCT07092852 2025-07-30

PGx Medication Safety Reviews of Persons With IDD

Not yet recruiting

700 enrolled

Developmental Disabilities, Lymphoma, Follicular, Intellectual Disability

NCT04159779 2025-07-17

A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

180 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05555979 2025-06-29

ELECTRIC

56 enrolled

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05541341 2025-06-06

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

200 enrolled

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06422247 2025-06-04

Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

307 enrolled

Lymphoma, T-Cell, Peripheral

NCT06790420 2025-05-31

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

1 enrolled

Infections, Lymphoma

NCT05958134 2025-05-23

Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL

600 enrolled